Filing Details
- Accession Number:
- 0001214659-24-018899
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-13 18:55:07
- Reporting Period:
- 2024-11-11
- Accepted Time:
- 2024-11-13 18:55:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 791908 | Xoma Royalty Corp | XOMA | Pharmaceutical Preparations (2834) | 522154066 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1575933 | Owen Hughes | C/O Xoma Royalty Corporation 2200 Powell Street, Suite 310 Emeryville CA 94608 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-11-11 | 53,360 | $0.00 | 56,860 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-11-13 | 21,881 | $29.95 | 34,979 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Performance Stock Units | Disposition | 2024-11-11 | 53,360 | $0.00 | 53,360 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 221,640 | 2026-05-18 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Depositary Shares - 8.375% Series B Perpetual Preferred | 2,000 | Direct |
Footnotes
- Shares sold to satisfy the tax withholding obligations incurred upon settlement of the Performance Stock Units ("PSUs").
- The price reported represents the weighted average sale price of the shares. The shares were sold in multiple transactions at prices ranging from $29.93 to $30.38 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- Each PSU represents a contingent right to receive one share of the Issuer's common stock (the "Common Stock"). The PSUs vest upon the Common Stock achieving a specified price per share.
Billionaire Hedge Funds
